Announcement of the Bike Rental Program We are pleased to announce the launch of a new Bike Rental Program starting next semester. This initiative aims to promote sustainable transportation and provide students with an affordable, convenient commuting option. Bicycles will be available for rent at multiple stations across the campus. Students can rent a bike for a nominal fee using their university ID card. The program is designed to reduce traffic congestion and parking issues, while also encouraging a healthy lifestyle among students. Student Conversation [Student A]: Hey, did you hear about the new Bike Rental Program the university is starting? [Student B]: Yeah, I did. I think it’s a great idea! [Student A]: Really? Why do you think so? [Student B]: Well, first of all, the campus is always crowded with cars, and parking is such a hassle. Having bikes available will definitely help with that. Plus, it’s such a cheap option compared to driving or even taking the bus. [Student A]: That’s true. I guess it could save some money. [Student B]: Exactly! And you know, riding a bike is a great way to get some exercise. I sit in lectures all day, so any chance to be active is a plus for me. Overall, it's a win-win situation. Summary of the Announcement The reading passage announces a new Bike Rental Program at the university that offers bikes for rent to students for a small fee. In the conversation, Student B supports this program. They believe it will help reduce traffic congestion and parking problems on campus. They also think it's a more affordable commuting option compared to driving or using the bus. Additionally, Student B mentions that riding a bike is a good way to incorporate exercise into their daily routine, as they spend a lot of time sitting in lectures. Overall, they see the program as beneficial for both transportation and health.

Omalizumab, marketed under the brand name Xolair, is a monoclonal antibody used primarily to treat moderate to severe persistent asthma that's not adequately controlled with inhaled corticosteroids. It's also used for chronic idiopathic urticaria (chronic hives) that doesn't respond to antihistamines. Omalizumab works by targeting and binding to immunoglobulin E (IgE), a substance in the body that plays a key role in allergic reactions. By reducing free IgE levels, the medication helps decrease the allergic response and inflammation in the airways, leading to fewer asthma attacks and less severe symptoms.Administered via subcutaneous injection, typically every two to four weeks, the dosage of omalizumab depends on the patient's weight and IgE levels. As with any medication, there are potential side effects, including injection site reactions, headaches, and an increased risk of infections. In rare cases, it can cause severe allergic reactions, so it's important for patients to be monitored by healthcare professionals during treatment.If you're considering omalizumab as a treatment option, it's essential to consult with your healthcare provider to determine if it's appropriate for your condition and to discuss any potential risks and benefits.